(Q40412650)

20 September 2017

title

Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients (English)

1 reference

20 September 2017

Nuray Buyukberber

1

1 reference

20 September 2017

Süleyman Buyukberber

series ordinal

2

1 reference

20 September 2017

Alper Sevinc

series ordinal

3

1 reference

20 September 2017

Celalettin Camci

series ordinal

4

1 reference

20 September 2017

publication date

7 August 2008

1 reference

20 September 2017

1 reference

20 September 2017

volume

26

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

55-61

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-008-9081-z

20 September 2017

exact match

0 references

cites work

Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9081-Z

A Prospective Study of Daily Measurement of C-Reactive Protein in Serum of Adults with Neutropenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9081-Z

Interleukin-8 serum levels for early detection of infectious episodes in neutropenic patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-008-9081-Z

Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia

21 January 2018

1 reference

12 December 2020

Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia

1 reference

12 December 2020

Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

12 December 2020

Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia

1 reference

12 December 2020

Interleukin 8 in serum in granulocytopenic patients with infections

1 reference

12 December 2020

Risk assessment and treatment of low-risk patients with febrile neutropenia

1 reference

12 December 2020

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

12 December 2020

Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy

1 reference

12 December 2020

TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values

1 reference

12 December 2020

"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia

1 reference

12 December 2020

Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.

1 reference

12 December 2020

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

1 reference

12 December 2020

Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer

1 reference

12 December 2020

Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia

1 reference

12 December 2020

Out-patient management of febrile neutropenia

1 reference

12 December 2020

Interleukin-6 (IL-6) levels in febrile children during maximal aplasia after bone marrow transplantation (BMT) are similar to those in children with normal hematopoiesis

1 reference

12 December 2020

Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia

1 reference

12 December 2020

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia

1 reference

12 December 2020

Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia

1 reference

12 December 2020

Risk factors assessment in fabrile neutropenia

1 reference

12 December 2020

An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients

1 reference

12 December 2020

Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy

1 reference

12 December 2020

Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever

1 reference

12 December 2020

Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications

1 reference

12 December 2020

C-reactive protein for rapid diagnosis of infection in leukaemia

1 reference

12 December 2020

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.

1 reference

12 December 2020

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

12 December 2020

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients

1 reference

12 December 2020

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.

1 reference

12 December 2020

Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein

1 reference

12 December 2020

Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia

1 reference

12 December 2020

The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.

1 reference

12 December 2020

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

12 December 2020

10.1007/S12032-008-9081-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1018446500

0 references

1 reference